Chapter 50: Cardiovascular Medications

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

It really hits you how intricate our cardiovascular system is when you realize the sheer number of medications designed just to keep it running smoothly.

It absolutely does.

It's a real deep dive into the complexities of heart health that we're embarking on today looking at, well, the cornerstone medications used in health care.

Precisely.

And we have a very detailed chapter as our guide for this exploration.

It truly lays out the vast landscape of cardiovascular pharmacology.

We'll be navigating everything from medications that influence blood clotting, you know, like anticoagulants and antiplatelets, which are crucial for preventing dangerous thrombi, to those that manage blood pressure, the antihypertensives.

Right, like diuretics and various adrenergic blockers.

Exactly.

And even cardiac glycosides, antianginals, it's a lot.

And there's even more ground to cover.

We're also going to unravel how thrombolytics work, you know, breaking down existing clots in critical situations.

Then there's the role of cardiac glycosides like digoxin and heart failure, the mechanisms of antianginals for easing chest pain, as well as beta blockers, calcium channel blockers, vasodilators, and finally, the antilipimics that target cholesterol levels.

It's well, it's a comprehensive field.

It really is.

And our goal here is really to pull out the vital knowledge about each of these categories, you know, how they work, when they're indicated, and what you really need to watch out for, both as clinicians and individuals.

Absolutely.

And as we delve into these medications, let's try and keep two fundamental concepts in mind.

Clotting, that's the body's intricate process of forming and dissolving blood clots and perfusion.

Perfusion, right.

Delivering oxygenated blood and nutrients everywhere.

Exactly.

These two concepts are really central to why these medications are so critical in managing cardiovascular health.

They really are.

And before we get started, here's a little scenario to think about, something that came directly from our source material.

It highlights the practical nature of what we'll be discussing.

Okay.

Imagine a nurse has a client on warfarin, and the latest INR result comes back, 2 .8.

What should the nurse do?

Hmm.

Good question.

A very real -world scenario.

Exactly.

We'll revisit this and give the answer later, but it's a great lens, you know, to view the importance of really understanding these medications.

Okay, let's start our deep dive with anticoagulants.

These are the meds focused on preventing problematic blood clots hitting our first priority concept,

clotting.

Right.

So, anticoagulants, as their name suggests, they're all about hindering the formation of blood clots.

Okay.

They don't actually break down clots that have already formed, but they work by interfering with different stages of the body's natural clotting cascade.

This ultimately reduces the blood's tendency to coagulate.

The clotting cascade, like a series of steps.

Yeah, think of it like a domino effect involving various proteins in the blood.

When they're activated in sequence, you get a stable clot.

Anticoagulants basically interrupt that sequence at specific points.

Okay.

And our source highlights that these are essential when there's evidence of clots already or a really high risk of them developing.

That's right.

Conditions like MI, heart attack, unstable angina.

Severe chest pain.

Right.

Atrial fibrillation, that irregular heart rhythm,

DVT, PE, and even in people with mechanical heart valves.

Anywhere clots are likely.

And it's just as crucial to know when not to use them.

The contraindications generally include active bleeding.

Makes sense.

Except in very specific complex situations like DIC.

Also, known bleeding disorders, active ulcers, significant liver or kidney disease, or a history of hemorrhagic stroke bleeding in the brain.

Right.

And like all potent medications, they come with potential side effects.

The big one, obviously, is the risk of hemorrhage.

Excessive bleeding.

Exactly.

Our source lists several signs.

Hematuria, blood in urine, epistaxis, nosebleeds.

Ecomosis, easy breathing.

Bleeding gums, even thrombocytopenia, low platelets, and hypotension, low blood pressure, maybe from bleeding.

All signs to watch for, definitely.

Okay, let's focus on some specific anticoagulants now, starting with heparin sodium.

Okay, heparin.

Its main action is to prevent thrombin, that's a key enzyme, from converting fibrinogen into fibrin.

And fibrin is the stuff that makes the clot structure.

Precisely.

It's the stringy protein that forms the framework.

So by blocking that conversion, heparin effectively helps prevent thromboembolisms, clots traveling and lodging somewhere dangerous.

But it won't dissolve an existing clot.

Correct.

Its role is prophylactic, preventing new ones or the extension of existing ones, not dissolving.

Okay, so how do clinicians know if it's working correctly?

How do they monitor it?

That's where blood tests come in, right?

Specifically, the APTT.

That's the one.

Activated Partial Thromboplastin Time, or APTT.

Our source says the normal range is typically around 30 to 40 seconds, though that can vary slightly depending on the lab.

Right.

Now what's interesting here is when a patient is on a continuous heparin infusion, the goal therapeutically is usually to keep their APTT at about 1 .5 to 2 .5 times their normal baseline value.

Okay, so thinner than normal, but not too thin.

Exactly.

It reduces clot risk without causing spontaneous bleeding, ideally.

But as the source points out, protocols can differ.

Some places might aim a bit lower for, say, acute coronary syndromes, maybe a slightly different range for DVT or PE.

That makes sense.

Different situations need different levels of anticoagulation.

And it sounds like monitoring that APTT is pretty frequent, especially at the start.

Oh, absolutely.

The source specifies checking it typically every four to six hours during the initial continuous infusion.

Wow, okay.

Once things stabilize, the patient's condition and the APTT levels, then the frequency usually drops to maybe daily monitoring.

But again, hospital policies vary.

The result directly guides the heparin dose adjustment.

So if the APTT is too long, dose gets lowered, blood's too thin, and if it's too short, dose likely gets increased, risk of clotting might still be too high.

Understood.

So careful, frequent monitoring, precise dosage adjustments, essential with heparin.

What specific nursing interventions are important, then?

Several key things.

Continuous monitoring of both APTT and platelet count is vital.

Right.

Nurses also need to be super vigilant for any signs of bleeding.

We mentioned them earlier.

Bleeding gums, easy bruising, nosebleeds, blood and urine, or stool sometimes hidden.

So checking for occult blood is important.

Vomiting blood, petechia.

Yeah.

Little spots.

Exactly.

Those tiny red or purple spots on the skin,

all potential signs.

And what about when heparin is given subcutaneously, not IV?

Ah, yes.

The technique for subcutaneous injection is quite specific.

Our source emphasizes injecting it into the abdominal tissue, usually with a 58 -inch natal, 25 to 28 gauge, at a 90 -degree angle.

And importantly, you don't aspirate, don't pull back the plunger before injecting, and you don't rub the site afterwards.

Got it.

And for the continuous IV heparin, you mentioned an infusion pump.

Absolutely necessary.

Insures a consistent, accurate rate.

Crucial for safety.

Moving on to inoxaparin.

Our source calls it a low -molecular -weight heparin.

How's it different from standard heparin?

Well, inoxaparin works fundamentally the same way and has similar uses, but, and this is important, they are not interchangeable.

A big difference is that inoxaparin has a longer half -life.

Its effects last longer.

So maybe less frequent dosing.

Often, yes.

Typically once or twice a day, which can be more convenient.

And administration, is that the same?

Not quite.

The source stresses inoxaparin is only subcutaneous, and specifically into the anterolateral or post -rolateral abdominal wall, while the client is lying down, actually.

Interesting.

Another key point, don't expel the air bubble from the pre -filled syringe.

And again, no aspiration,

monitoring for bleeding is just as crucial as with standard heparin.

And good news, they share the same antidote if there's an overdose,

protamine sulfate.

Okay, good to know.

Now, let's talk about warfarin sodium, probably one of the most common oral anticoagulants, right?

Definitely one people are familiar with.

Warfarin's mechanism is different from heparin's, it doesn't directly hit thrombin.

Instead, it acts as a vitamin K antagonist.

Vitamin K, the clotting vitamin.

Exactly.

Vitamin K is essential for the liver to make several key clotting factors, specifically factors X, IX, VII, and II.

Warfarin interferes with vitamin K's role, so it indirectly suppresses coagulation.

And the monitoring is different, too.

Did we mention PT and INR earlier?

That's correct.

Warfarin's effect on prolonging clotting time is monitored using the prothrombin time, or PT,

and the International Normalized Ratio, or INR.

Okay.

Our source indicates the normal PT is usually around 11 to 12 .5 seconds.

When someone's on warfarin, the therapeutic target for PT is typically 1 .5 to 2 times their control value, their PT, before starting warfarin.

Now, the INR seems to be the one you hear about most often.

It's more standardized.

It is, yes.

The normal INR for someone not on warfarin is roughly 0 .81 to 1 .2.

The INR is actually calculated from the patient's PT result compared to a control, and then adjusted using a correction factor specific to the lab regent used.

Ah, so it makes results comparable between different labs.

Precisely.

Leads to more consistent management of anti -coagulation, which is really important.

So what's the target INR range when someone is taking warfarin?

Well, the goal is to get the INR up to a level that's right for the specific condition being treated.

For standard therapy, the typical target INR range is between 2 and 3.

However, for some conditions, like certain types of mechanical heart valves, you might need a higher INR target, say 3 to 4 .5.

Right.

The source also notes that if a patient on standard therapy has a PT over 30 seconds and an INR over 3 .0, you really need to implement bleeding precautions to minimize risk.

And what if the INR falls outside that desired range, below 2 or above 3, for instance?

Good question.

If the INR is below the therapeutic range, the warfarin dose likely needs to be increased to get enough anti -coagulation.

Okay.

Conversely, if it's too high, that means increased bleeding risk, so the dose would typically be reduced, or maybe even held for a day or two.

Right.

The source also mentions bridge therapy.

This is where you use a faster -acting anticoagulant, like heparin, or low -molecular -weight heparin, at the same time as starting warfarin.

Why do that?

Because warfarin takes several days to reach its full effect.

The bridge therapy provides immediate protection until the INR gets into the target range.

Then, the bridging drug is usually stopped, and the patient continues on warfarin alone.

Ah, that makes sense.

Covers the gap.

So, what are the crucial nursing interventions for patients on warfarin?

Very similar vigilance as with heparin.

Regular monitoring of PT and INR is absolutely key for dosage adjustments.

And that vigilant observation for any signs of bleeding gums, bruises, nosebleeds, blood in urine or stool, vomiting blood, petechiae, also crucial.

And patient education.

Huge role for nurses there.

Reinforcing measures to prevent bleeding, soft toothbrush, electric razor instead of blades, avoiding risky activities.

And, just like heparin has protamine sulfate, warfarin has a specific antidote too.

Phytonadione, which is vitamin K.

Okay.

We've covered the more traditional oral anticoagulant, but our source also discusses some of the newer ones, the DOACs.

Direct oral anticoagulants, like davigantran and rivaroxaban.

How do they stack up?

Right, the DOACs.

They offer several advantages, maybe the biggest being that they generally don't require that routine blood monitoring like warfarin does.

That's a big difference.

It is.

Davigantranatexolate works by directly inhibiting thrombin, blocking that key enzyme we talked about.

So it stops fibrinogen converting to fibrin and also inhibits factor third activation.

Okay.

Its main indication currently is preventing stroke and systemic embolism in nonvalvular atrial fibrillation.

And it's usually a fixed dose, twice a day.

So no regular INR checks for patients on davigantran?

Correct.

The source explicitly says routine coagulation monitoring isn't required.

But, and this is important, the general nursing responsibilities, observing for bleeding, educating the patient about precautions, those still absolutely apply.

Same as with warfarin or heparin.

Okay.

And rivaroxaban,

different mechanism.

Slightly different target.

Rivaroxaban directly inhibits factor sac, that's another crucial enzyme, but it's a bit earlier in the coagulation pathway before thrombin.

Right.

It's approved for several things.

Stroke prevention and nonvalvular AFib, preventing DVT -PE after knee or hip replacement, and also treating existing DVT and PE.

And monitoring.

Similar to davigantran, routine blood monitoring generally isn't required.

Again, nursing interventions focus primarily on assessing for and preventing bleeding.

Our source also mentions box 501, which I assume lists all these anticoagulants.

Yes, handy reference.

And box 52, which lists medications to avoid when taking anticoagulants.

Sounds important.

Extremely important.

Box 52 highlights a wide range of potential interactions.

Drugs like allopurinol, semetidine, corticosteroids, even certain herbal supplements like ginkgo and ginseng.

NSAIDs too, like ABPROFIT.

Yes.

NSAIDs, oral hypoglycemic, finitoin, salicylates like aspirin, sulfonamides.

The list goes on.

It really underscores why getting a thorough medication history, including all over -the -counter stuff and supplements, is critical before starting any anticoagulants.

Definitely.

Okay, that's a great overview of anticoagulants preventing clots.

Let's switch gears now to thrombolytic medications.

These sound like the ones that actually tackle clots that have already formed.

That's a good way to put it.

Thrombolytics work by activating plasminogen.

That's a protein naturally present in our blood.

When plasminogen gets activated, it turns into plasmin.

And plasmin is an enzyme that can actually break down existing blood clots by degrading fibrin, that main structural component we talked about.

So these are the clotbusters, the go -to drugs when a clot is causing a major problem.

Precisely.

Our source really emphasizes their critical role early in managing a heart attack myocardial infarction.

Ideally, given within four to six hours of symptoms starting.

Why so quickly?

The goal is to rapidly restore blood flow to the heart muscle that's being starved of oxygen.

This limits the damage, preserves heart function, especially the left ventricle, and ultimately reduces the risk of dying.

Makes sense.

But their use isn't just limited to heart attacks.

They can also be used for acute arterial thrombosis, DVT, occluded shunts or catheters, and pulmonary embolism.

Given that potent clot dissolving action, I bet there are some significant contraindications.

You are absolutely right.

The list is pretty extensive because of that inherent bleeding risk.

Active internal bleeding, obviously.

A history of hemorrhagic stroke,

any known intracranial problems like recent head trauma,

recent major surgery intracranial intraspinal within two months, or thoracic pelvic abdominal within 10 days.

Also, a history of significant liver or kidney disease,

uncontrolled severe hypertension, recent prolonged CPR, or a known allergy to the thrombolytic agent itself.

That's a hefty list of risks to weigh.

What are the main side effects then?

Besides the bleeding risk.

Bleeding is definitely the number one concern.

It can range from minor oozing to severe life -threatening internal hemorrhage.

Right.

Dysrhythmias, irregular heart rhythms can also happen.

Sometimes thought to be due to the rapid reperfusion, restoring blood flow to damaged tissue, and of course, allergic reactions to the drug are possible.

So what kind of monitoring and nursing interventions are critical when someone's getting a thrombolytic?

Sounds intense.

It is.

Meticulous monitoring is absolutely paramount.

You need baseline labs before starting APTT, PT fibrinogen, hematocrit, platelet count.

Vital signs need to be checked very frequently.

Peripheral pulses assessed regularly to check perfusion.

And nurses have to be extremely vigilant for any sign of bleeding.

That means checking all excretions, urine, stool, vomit for occult blood.

And neurological status.

Critical.

Needs close, frequent assessment.

Looking for subtle changes, slurred speech, new confusion or lethargy, weakness on one side, any hint of bleeding in the brain.

Also watching closely for hypotension and tachycardia, which could signal significant blood loss.

It sounds like you want to minimize any potential bleeding sites.

What about things like injections or blood draws?

Good point.

The source strongly advises avoiding any unnecessary injections or venipunctures.

Minimize the risk.

Right.

If a puncture is necessary, you need to apply direct pressure to the site for a long time afterwards, typically 20 to 30 minutes to make sure it stops bleeding.

Wow, 20 to 30 minutes.

And handle the patient very gently when moving or repositioning them.

Instruct them to use an electric razor, a soft toothbrush.

If any bleeding is seen, the infusion has to be stopped immediately and the provider notified right away.

Is there an antidote for thrombolytics if bleeding gets out of control?

Yes, there is.

Aminocaproic acid.

But our source notes, it's usually reserved for really acute, life -threatening bleeding situations because it has its own potential side effects.

Okay.

And box 50 to 3 in source lists common thrombolytics like Altaplase, TPA, Ritaplase, Tenectaplase.

That's right.

Those are some of the main ones.

Okay.

So we've covered preventing clots and dissolving clots.

Now let's turn to antiplatelet medications.

How are these different from anticoagulants?

They both prevent clots, right?

They both aim to prevent harmful clots, yes, but they work differently.

Antiplatelet meds specifically target platelets.

The little blood cells involved in clotting.

Exactly.

They inhibit the aggregation, the clumping together of platelets.

Platelets are crucial in the very first steps of clot formation sticking to damaged vessel walls and each other.

By stopping that clumping, antiplatelets prolong bleeding time.

And are they used in the same situations as anticoagulants?

There's definitely some overlap, and sometimes they're even used with anticoagulants.

But antiplatelets are often a cornerstone for long -term prevention prophylaxis of serious cardiovascular events.

Think after a heart attack, after coronary procedures like getting a scent, or in people at high risk for stroke.

Are there specific contraindications for antiplatelets?

Similar to anticoagulants, yeah.

Generally contraindicated if someone has a known bleeding disorder like hemophilia or severe low platelets.

Or if they have a known allergy or sensitivity to that specific antiplatelet drug.

And the side effects.

Yeah.

Still mainly bleeding related.

Primarily, yes.

Increased risk of bleeding.

That might show up as GI bleeding, maybe belly pain, nausea, dark stools.

Or increased bruising, blood in the urine, nosebleeds.

So nursing interventions would focus on watching for those bleeding signs again.

Precisely.

Before giving the first dose, check for allergies or sensitivities.

Monitor vital signs.

If it causes GI upset, taking it with food often helps.

Bleeding time might be monitored if ordered.

And patient education again.

Crucial.

Educating patients about bleeding risks and reinforcing precautions.

Box 50 -4 in our source list.

Common antiplatelets.

Aspirin, clopetogrel, proshagrel, ticagrelor are some big ones.

Available orally and sometimes parenterally too.

Okay.

Let's shift focus now to a different class.

Cardiac glycosides.

Specifically, digoxin.

I usually associate this one with heart failure.

That's a primary use.

Although our source notes, it's often considered more of a second line agent now for heart failure.

First line therapies often target the RAAS system.

Renin angiotensin aldosterone.

Ah, okay.

So how does digoxin work?

Digoxin is a cardiac glycoside.

It works by inhibiting the sodium potassium pump.

The NA plus bash FK plus ATPase pump in heart muscle cell.

Okay.

What does that do?

Inhibiting that pump leads to more sodium inside the cell.

Which then promotes calcium coming into the cell.

More intracellular calcium means a more forceful contraction of the heart muscle.

We call that a positive inotropic effect.

So digoxin helps the heart pump stronger.

Exactly.

But it does other things too.

It has a negative coronotropic action, meaning it slows the heart rate acting on the SA node, the natural pacemaker.

Okay.

And it has a negative dramatropic action, slowing down electrical impulse conduction through the AV node, which controls signals going from the atria to the ventricles.

So stronger pump, slower rate, slower conduction.

Right.

The overall result is improved cardiac output, reduced preload, the filling pressure in the ventricles, better blood flow out to the body and kidneys, less edema, and more fluid excretion.

So it strengthens the pump and helps manage fluid overload.

That sounds very useful in heart failure.

Precisely.

That combination of effects is why it can be beneficial for heart failure symptoms.

It can also help control the heart rate in certain fast atrial rhythms like AFib or atrial flutter.

Although beta blockers and calcium channel blockers are often used more for rate control now.

Are there times you wouldn't use digoxin?

Definitely.

It's contraindicated in patients with ventricular dysrhythmias and second or third degree heart block, as it could make those worse.

And you need caution with renal impairment, hypothyroidism, and low potassium levels hypokalemia.

Right.

And figure 51 in the source shows that vicious cycle of heart failure.

Yes, it's a helpful visual.

Yeah.

Shows how digoxin can interrupt some of those harmful compensatory mechanisms.

That digoxin is famous or maybe infamous for having a narrow therapeutic index, right?

Yeah.

Small window between effective dose and toxic dose.

That's a critical point with digoxin, very narrow window.

So what are the warning signs of toxicity early and late?

Good question.

Early signs often involve the GI system, anorexia, loss of appetite, nausea, vomiting, diarrhea.

Okay.

As toxicity progresses, you might see later signs like headache, visual disturbances, diplopia, double vision,

blurred vision, seeing yellow -green halos around lights, photophobia, light sensitivity.

Yellow -green halos, that's distinctive.

It is.

Patients might also get drowsy, have significant bradycardia, slow heart rate, fatigue, muscle weakness.

The typical progression is often GI symptoms first, then heart rate changes, then the visual stuff.

So what specific things should nurses monitor closely in patients on digoxin?

Continuous, careful monitoring for any of those toxicity signs and symptoms is number one.

Right.

That includes actively assessing for those signs, plus regularly checking the serum digoxin level itself, electrolytes especially, potassium, calcium, and magnesium, and kidney function tests like BUN and creatinine.

What's the target digoxin level?

The therapeutic range is generally considered 0 .8 to 2 .0 nanograms per milliliter NGML.

It's quite low.

And certain conditions increase the risk of toxicity.

Yes, significantly.

Things like hypercalcemia, high calcium, hypokalemia, low potassium, hypomagnesemia, low magnesium, or hypothyroidism.

Monitoring potassium is especially key.

The provider needs to know if potassium drops below 3 .5 millilucule because low potassium really enhances digoxin's effects and toxicity risk.

Are there other medication interactions to watch out for?

Patients should avoid over -the -counter meds without checking first, as many can interact.

Also, patients on potassium -wasting diuretics like furosemide or hydrochlorothiazide or corticosteroids need very close monitoring for hypokalemia, which ups the toxicity risk.

Older adults are generally more sensitive, too.

So encourage potassium -rich foods.

Definitely.

And before giving any dose of digoxin, the nurse absolutely must check the apical pulse for a full minute.

A full minute, why?

To get an accurate rate and rhythm.

If the rate is below 60 beats per minute or significantly above their baseline, say over 100, you hold the dose and notify the provider.

Patients and families also need teaching how to take their own pulse, when to call the provider, and importantly, recognizing those signs and symptoms of toxicity and reporting them immediately.

And there's an antidote for severe toxicity.

Yes, digoxin immune fab, also called Digibind, used for severe cases.

Okay, that's a very thorough look at digoxin.

Let's move on now to antihypertensive, starting with diuretics.

Our source mentioned several classes here.

That's right.

Box 50 -5 breaks them down.

Thiazide diuretics, loop diuretics, osmotic diuretics, which we'll just touch on.

Chapter 56 covers them more, and potassium -sparing diuretics.

Let's start with thiazides.

Think hydrochlorothiazide.

Box 50 -6 lists more.

Okay.

How do thiazides lower blood pressure?

They mainly work in the distal convoluted tubule of the kidney.

They increase sodium and chloride excretion and water follows by inhibiting sodium reabsorption there.

So less fluid volume means lower pressure.

Exactly.

And it helps with peripheral edema, too.

But they're not for immediate rapid diuresis, and they work best if kidney function is relatively normal, generally contraindicated in significant renal failure.

Any key drug interactions.

Need caution with lithium risk of toxicity goes up.

Also potential interactions with digoxin, corticoceroids, and hypoglycemic meds.

Thiazides can affect how those work.

What about side effects of thiazides?

Key ones are electrolyte imbalances.

You can see hypercalcemia, hypoglycemia, hyperglycemia, high blood sugar, hyperuricemia.

Hydric acid can trigger gout.

And also hypokalemia, low potassium, hyponatremia, low sodium.

Plus potential for hypovolemia, low volume leading to hypotension and dehydration.

Rashes and photosensitivity can happen, too.

So what nursing interventions are key for thiazides?

Careful monitoring of vitals, especially blood pressure.

Also weight, urine output, and those serum electrolytes, glucose, calcium, BUN, creatinine, and uric acid.

Assessing for edema.

Advise taking it in the morning to avoid nighttime urination.

Teach home BP monitoring.

Encourage potassium -rich foods or supplements, if prescribed, to counter hypokalemia.

Take with food for GI upset?

Change position slowly.

Use sunscreen.

All good points.

Taking with food can help.

Definitely change position slowly for orthostatic hypertension risk.

And yes, use sunscreen due to photosensitivity.

Diabetics need to monitor blood glucose closely, too, as thiazides can affect it.

Okay.

Next up, loop diuretics, like furosemide -gubatinide, listed in box 57.

How do these compare to thiazides?

Loop diuretics are generally more potent.

Stronger diuretics?

They inhibit sodium and chloride reabsorption, not just in the distal tubule, but more significantly in the loop of henolol, a different part of the kidney tubule.

More potent.

So more fluid loss.

Yes.

Usually a more rabid and significant diuresis.

They cause more water and electrolyte depletion.

They have less effect on blood sugar than thiazides, but can still increase uric acid.

And they also promote calcium excretion, unlike thiazides.

So lower calcium levels.

Potentially, yes.

Because they're so potent, they cause a bigger drop in vascular volume, cardiac output, and blood pressure.

They're often used for hypertension, pulmonary edema, heart failure edema,

hypercalcemia, and in renal disease.

Interactions similar to thiazides.

Digoxin lithium?

Yes.

Caution with those.

Also, with eminoglycoside antibiotics, increased risk of hearing damage,

ototoxicity, and anticoagulants, corticosteroids, amphotericin B.

And the side effects for loop diuretics.

More intense electrolyte loss.

Can be.

Besides hypokalemia and hyponatremia like thiazides, loop diuretics can also cause hypocalcemia, low calcium, and hypomagnesemia, low magnesium.

Okay.

Other possibilities.

Thrombocytopenia, low platelets, hyperuricemia, orthostatic hypotension, rash,

that ototoxicity risk, especially with rapid IV injection, thiamine deficiency, and dehydration because they pull off so much fluid.

Nursing interventions for loops.

Yeah.

Mostly similar to thiazides, but maybe more intense monitoring.

Pretty much.

Monitoring vitals, weight, INO, electrolytes, sodium, potassium, chloride, glucose, BUN, creatinine, uric, acid, all that.

Plus, specifically monitor calcium and magnesium levels due to the higher risk of loss.

Assess edema, teach about timing, morning home BP checks, potassium -magnesium intake, changing positions slowly, sun protection, all still apply.

Vigilance for digoxin or lithium toxicity is heightened because electrolyte shifts make it more likely.

And remember, administer thiavee furosemide slowly to reduce that hearing loss risk.

Okay.

We'll skip the details on osmotic diuretics for now, per the source.

Let's talk potassium -sparing diuretics.

Spironoloxone, triamterine, box 50 -8.

The name says a lot, right?

It does.

They act mainly on the distal tubule, promoting sodium and water excretion, but crucially holding onto potassium.

So, use when you want diuresis, but need to avoid potassium loss.

Exactly.

Okay.

For edema, hypertension, treating fluid overload and heart failure or ascites, or treating low potassium caused by other diuretics.

Contraindications.

Severe kidney or liver disease, and pre -existing severe hyperkalemia, high potassium.

Need caution with diabetes, other antihypertensives, lithium.

And especially avoid using with ACE inhibitors or potassium supplements big risk of hyperkalemia then.

That's the main concern, high potassium.

Makes sense.

Side effects besides hyperkalemia.

Nausea, vomiting, diarrhea can happen.

Rash, dizziness, weakness, headache, dry mouth, photosensitivity.

Less commonly, anemia or thrombocytopenia.

Spironolactone can have some hormonal side effects too.

Key nursing interventions for potassium spares.

Focus on potassium levels.

Absolutely.

Monitor vitals, urine output.

Be super vigilant for signs and symptoms of hyperkalemia, nausea, diarrhea, cramps, maybe tachycardia, then bradycardia.

Peaked T waves on ECG, low urine output.

Check serum potassium regularly above 5 point over EQL is generally hyperkalemic.

And dietary advice.

Instruct patients to avoid high potassium foods and salt substitutes, which often contain potassium chloride.

Also avoid direct sunlight due to photosensitivity.

Taking it with meals might help GI upset.

Okay, that covers the diuretics.

Now, our source moves to peripherally acting alpha adrenergic blockers.

Box 50 -9.

How do these lower blood pressure?

These drugs like prozacin, terrazosin, doxazosin, work by decreasing sympathetic vasoconstriction out in the periphery.

Wow.

They reduce norepinephrine's effects at the alpha receptors on blood vessels.

This causes vasodilation vessels widen, reducing peripheral resistance and thus lowering blood pressure.

A bonus is they usually don't harm renal blood flow, might even improve it.

Often used for hypertension, especially in men who also have BPH as they relax prostate muscle too.

Side effect.

Main ones are orthostatic hypotension dizziness when standing up, especially early on or with those increases.

Reflex tachycardia heart speeds up to compensate for the BP drop.

Also sodium water retention, GI upset, drowsiness, nasal congestion, edema, weight gain.

So patient education about orthostatic hypotension is critical here.

Absolutely crucial.

Monitor vitals, especially orthostatics.

Assess for fluid retention, edema.

Teach patients to change positions, slowly sit before standing, etc.

To minimize dizziness and falls.

Home BP monitoring.

Watching for swelling or weight gain.

Reducing salt intake helps manage fluid retention.

And advise avoiding OTC cold allergy meds without checking first as some can interfere.

Okay.

Next are centrally acting sympathetic or adrenergic blockers.

Box 5010.

How are these different from the peripheral ones?

These like clonidine and methyl dopa work in the central nervous system, specifically the brain stem.

They actually stimulate alpha receptors there.

Stimulate?

Doesn't that raise blood pressure?

Paradoxically, no.

Stimulating these specific central alpha receptors inhibits sympathetic outflow from the brain.

Less sympathetic activity means less vasoconstriction, lower peripheral resistance, and lower blood pressure.

They're also used for hypertension.

Contraindicated if liver function is impaired.

Side effects for the central one.

Can include sodium water retention, drowsiness, dizziness, dry mouth, bradycardia, slow heart rate, edema, impotence, hypotension, and even depression in some people.

Key nursing considerations.

Monitor vitals, BP, and heart rate.

May need to monitor liver function tests.

Educate about potential drowsiness, dizziness, fall precautions, and a really big one.

Do not stop these abruptly.

Why not?

Can cause severe rebound hypertension.

Blood pressure can shoot up dangerously high.

Needs gradual tapering under supervision.

Good to know.

Now we hit the really common ones.

ACE inhibitors and angiotensin II receptor blockers, ARBs.

Both listed in box 5011.

How do they work for blood pressure and heart failure?

Okay.

ACE inhibitors like glysopril, enalopril, captopril block the angiotensin -converting enzyme, ACE.

What does ACE do?

It converts angiotensin to angiotensin II.

Angiotensin II is a very potent vasoconstrictor.

It narrows blood vessels.

So blocking it causes vasodilation.

Exactly.

It lowers blood pressure.

ACE inhibitors also reduce aldosterone production.

That's a hormone causing sodium water retention.

Plus, they have a cardioprotective effect after heart attacks, reducing harmful heart remodeling.

And ARBs.

Yeah.

Like Losartan and Valsartan.

ARBs work a bit differently but have similar results.

They directly block angiotensin II from binding to its main receptors, type I, on blood vessels and other tissues.

This prevents the vasoconstriction and also blocks aldosterone release.

So same outcome, different mechanism.

Done.

Used for hypertension and heart failure, too.

Yes.

Widely used for both.

Generally, avoid using them with potassium supplements or potassium -sparing diuretics because of the increased risk of hyperkalemia.

Common side effects for ACEs and ARBs.

They share some.

Nausea, vomiting, diarrhea, hypertension, potential for hyperkalemia, tachycardia, headache, dizziness, fatigue, insomnia.

ACE inhibitors, though, are uniquely known for causing a persistent dry cough.

It's a very common reason people switch to an ARB.

Ah, the ACE cough.

Also, potential for hypoglycemia and diabetics, so need to monitor blood sugar.

Bruising, petechia can occur.

Diminished taste, especially early on with ACEs.

And a rare but serious side effect for both is angioedema swelling of face, lips, tongue, throat.

That's an emergency.

Key nursing interventions for ACEs, ARBs.

Regular monitoring of vitals, especially BP, kidney function tests, BUN, creatinine, electrolytes, especially potassium, maybe CBC periodically.

Monitor for hypoglycemia in diabetics.

Any specific administration tips.

Captopril should usually be taken 20 -60 minutes before meals for better absorption.

Monitor for bruising bleeding, especially with captopril.

Educate patients.

Don't stop abruptly.

Rebound hypertension risk.

Avoid OTCs without checking.

Monitor BP at home.

Warn about possible case changes initially.

And critically, report any signs of angioedema that swelling immediately.

Let's switch to anti -anginal medications now, specifically nitrates.

Box 5012, used for chest pain, angina.

Correct.

Nitrates, like nitroglycerin or isosorbidinitrate, work mainly by causing vasodilation -widening blood vessels.

How does that help angina?

Vasodilation reduces both preload, blood returning to the heart, and afterload, resistance the heart pumps against.

This decreases the heart's workload and oxygen demand, relieving the angina pain.

Pestoindications.

Significant hypotension, increased intracranial pressure, severe anemia,

and a major one.

Recent use of erectile dysfunction drugs like sildenafil or todalafil can cause severe, dangerous hypotension together.

Caution with severe kidney or liver disease.

And don't abruptly stop long -acting nitrates risk of rebound pain.

Side effects of nitrates.

Headache is very common, often described as throbbing.

Orthostatic hypotension causing dizziness, lightheadedness, weakness, faintness, nausea, vomiting,

flushing or pallor, dry mouth, and reflex tachycardia can happen due to the BP drop.

Nitrates come in many forms, right?

Sublingual, spray, patches, ointment.

Are there specific admin guidelines for each?

Yes, very important differences.

For sublingual tabs,

monitor vitals before and after.

A sip of water first can help dissolve it under the tongue if the mouth is dry.

Place under tongue, let dissolve, don't swallow.

And for chest pain?

Take one tablet.

If pain isn't relieved in five minutes, call 911 immediately.

In hospital, protocol is often one tab every five minutes, up to three doses.

Notify provider if first dose doesn't work.

Continue if BT -stable.

A stinging, burning sensation usually means the tablet is fresh.

Store them in a dark, tight glass bottle.

Acidaminophen often helps the headache.

Okay.

Translingual spray?

Spray onto oral mucosa, under tongue or inside cheek.

Don't inhale it.

Stain -release tablets.

Swallow whole.

Don't chew or crush.

Transothermal patch.

Apply to hairless skin area.

New patch, new site daily to avoid irritation.

Usually worn for 12 -14 hours, then a patch -free period of 10 -12 hours overnight to prevent tolerance.

Tolerance, the drug stops working as well.

Exactly.

The body gets used to it.

The patch -free time helps maintain effectiveness.

Topical lignin.

Remove the old dose first.

Squeeze prescribed length onto applicator paper.

Spread over a specific sized area, like 2 .5 by 3 .5 inches.

Chest, back, abdomen, upper arm, thigh avoid hair.

Cover with plastic wrap.

Rotate sites.

Don't touch the ointment directly.

So wear gloves when applying patches or ointment.

Absolutely.

Prevents you absorbing it.

Also, don't put patch assortment where defibrillator pads might go risk of burns during defibrillation.

And check expiration dates on the tablets.

Yes.

They lose potency quickly, often within six months of opening the bottle, even if the printed date is later.

The source also has a priority nursing actions box for test pain and hospitalized patients.

Assess oxygen -nitroglycerin protocol.

Monitor.

Very important sequence.

That's incredibly detailed.

Crucial info for using nitrate safely.

Let's move to beta -adgergic blockers.

Beta blockers.

Box 5013.

Another major class.

Right.

Beta blockers like metaprolol, atenolol,

propranolol.

They inhibit the response to beta -arginergic stimulation.

Basically, block the effects of adrenaline, epinephrine, and noradrenaline.

Part of the fight or flight response.

Exactly.

Blocking those effects leads to decreased heart rate, lower blood pressure, reduced heart workload, and less oxygen demand.

Uses.

Lots.

Angina, dysrhythmias, hypertension,

migraine prevention, preventing future heart attacks.

Contraindications.

Asthma or reactive airway disease risk of bronchospasm.

Bradycardia.

Uncontrolled heart failure.

Though some specific beta blockers are used in stable heart failure patients on ACEs diuretics.

Severe kidney liver disease, hyperthyroidism, stroke history, caution in diabetes.

They can mask hypoglycemia signs and caution with other antihypertensives additive effect.

What are the common side effects of beta blockers?

Bradycardia, bronchospasm, especially in susceptible people.

Hypotension, weakness, fatigue, nausea, vomiting, dizziness.

Less common.

Hyperglycemia, granulocytosis, low white cells, behavioral changes, depression, nightmares.

Nursing interventions for beta blockers.

Checking heart rate and BP is key.

Absolutely crucial.

Monitor vitals closely before every dose.

Hold and notify provider if heart rate is too low, if you're a G below 50 -60.

Or systolic BP too low, if you're example below 90 -100.

Monitor for signs of worsening heart failure, shortness of breath, swelling, weight gain.

And respiratory status.

Yes, check for respiratory distress, wheezing, dyspnea, especially in those with lung issues.

Instruct patients to report dizziness, lightheadedness, nasal congestion.

And again, do not stop abruptly.

Risk of rebound hypertension and angina again.

Yes, rebound hypertension, tachycardia, angina, even MI risk in patients with coronary disease.

Warn diabetics they might mask hypoglycemia signs, except sweating.

So monitor blood sugar closely.

Teach pulse BP taking.

Change position slowly.

Avoid OTC cold decongestant meds without checking first.

Next, calcium channel blockers.

Box 5014.

How do these work?

Calcium channel blockers, amlodipine, diltiazum, verapamil, are examples block calcium ions from entering smooth muscle cells in blood vessels and heart muscle cells.

What effect does that have?

In blood vessels, it causes relaxation and vasodilation, lowering BP and afterload.

In the heart, it reduces contraction force, negative anotropy, slows heart rate, negative chronotropy, especially verapamil diltiazum, and slows AV node conduction.

Negative dramotropy again, verapamil diltiazum mainly.

So overall, less workload for the heart.

Exactly.

Decreases myocardial oxygen demand, effective for angina, certain dysrhythmias, like SVTs, and hypertension.

Need caution with heart failure, bradycardia, AV block, as they can worsen those.

Side effects of calcium channel blockers.

Can include bradycardia, hypotension, reflex tachycardia, compensating for low BP, headache, dizziness, lightheadedness, fatigue.

Peripheral edema is quite common, especially ankles, legs, constipation, particularly with verapamil, flushing.

Changes in liver kidney function are possible?

Nursing interventions, similar monitoring.

Yes.

Regular monitoring of vitals, BP, heart rate.

Assess for heart failure signs, shortness of breath, weight gain, edema.

Liver enzymes, kidney function tests might be checked.

Don't stop abruptly rebound risk.

Teach pulse BP taking.

Report dizziness fainting.

Don't crush or chew sustained release forms.

Our source then discusses peripheral vasodilators.

Box 5015.

Mechanism and uses.

These act directly on smooth muscle of peripheral blood vessels, causing relaxation and widening.

Decreases peripheral resistance, increases blood flow to extremities.

So used for peripheral vascular disease.

Primarily yes.

Things like intermittent claudication, leg pain with walking, or Raynaud's phenomenon, vasospasm and finger stows.

Often most effective for vasospasm conditions.

Might also help symptoms of cerebral vascular insufficiency by improving brain blood flow.

Side effects, mostly related to the vasodilation.

Pretty much.

Lightheadedness, dizziness, orthostatic hypotension, reflex tachycardia, palpitations, flushing, GI distress.

Nursing monitoring for these.

Monitor vitals, orthostatics, BPHR lying in standing.

Watch for reflex tachycardia.

Assess extremities for signs of inadequate blood flow pallor, coldness, worsening pain.

Tell patients therapeutic effects might take time up to three months sometimes.

Strongly discourage smoking nicotine causes vasoconstriction, counteracting the drug.

Avoid aspirin unless approved.

Take with meals for GI upset.

Avoid alcohol enhances hypotension.

Change positions slowly.

The source also specifically mentions direct acting arterial or vasodilators.

Also in box 5015.

Hydrolazine, minoxidil, sodium nitric preside.

How do these work?

These directly relax smooth muscle and arterials, the small arteries.

Causes potent vasodilation, drops blood pressure.

Sounds powerful.

Downsides.

That potent vasodilation can trigger reflex sympathetic activation leading to reflex tachycardia, increased cardiac output.

Also causes sodium water retention leading to edema.

So they're often given with a diuretic and a beta blocker to manage those effects.

What are they used for?

Moderate to severe hypertension and acute hypertensive emergencies when you need rapid BP reduction.

They do increase blood flow to brain and kidneys.

Side effects.

Besides the reflex tachycardia and edema.

Hypotension, palpitations, dizziness, headache, nasal congestion, GI bleeding.

Neurological symptoms like confusion possible.

Sodium nitric preside has a specific risk of cyanide and thiocyanate toxicity, especially with prolonged use or high rates.

Requires very careful monitoring.

And remember, all vasodilators carry significant risk of orthostatic hypotension.

Nursing interventions for direct acting ones, especially nitric preside.

Continuous close monitoring of vitals, especially BP, is paramount.

For IV nitric preside, often in critical care, BP needs checking every few minutes initially than frequently.

May need to monitor cyanide to thiocyanate levels.

And it's light sensitive.

Yes.

Nitric preside decomposes in light.

The IV bag and tubing must be covered with an opaque sleeve.

Solution is usually stable only 24 hours.

Discard if it looks discolored, red, green, blue.

And due to the major orthostatic hypotension risk with all these, strict bed rest might be needed initially.

When ambulating, extreme caution, slow position changes, fall precautions are essential.

Finally, we get to anti -lipemic medications, Box 5016, for managing cholesterol and other lipids.

Correct.

Used to reduce elevated total cholesterol, triglycerides, and LDL cholesterol, the bad cholesterol.

High levels are major risk factors for coronary artery disease.

Lifestyle changes often aren't enough alone.

The source mentions bile acid sequestrants first.

How do they work?

Bile sequestrants, like cholestromine or cholecevelum, work in the intestines.

They bind to bile acids, which the liver makes to help absorb fat and cholesterol.

So binding them stops reabsorption.

Exactly.

The sequestrants prevent bile acids being reabsorbed.

This forces the liver to make more bile acids, and it uses up existing cholesterol to do that.

This lowers LDL cholesterol in the blood.

Any caveats?

Yeah.

Shouldn't be the only therapy.

If triglycerides are very high, they can sometimes increase triglycerides.

Side effects are mostly GI,

constipation, heartburn, nausea, belching, bloating.

Cholestomane is a powder, needs good mixing with liquid.

Monitor for peptic ulcer signs.

Advise taking with plenty of fluids to prevent constipation.

Okay.

Then the big category.

HMG -CoA reductase inhibitors, or statins.

Ornivastatin, simvastatin, lavastatin.

Very widely prescribed mechanisms.

Statins block an enzyme called HMG -CoA reductase.

This enzyme is key for the liver's cholesterol production pathway.

So blocking the enzyme means less cholesterol production.

Right.

Reduces liver cholesterol production, which lowers LDL cholesterol in the bloodstream.

Lavastatin is highly protein -bound.

Note potential interactions like with anticoagulants.

Generally avoid combining statins with gymfibrosil, another lipid drug.

Use caution with immunosuppressants.

I have a fix of statin.

It can include nausea, diarrhea, or constipation, abdominal pain cramps, gas, dizziness, headache, blurred vision, rash, itching.

Elevated liver enzymes are possible.

Muscle cramps or fatigue, too.

So monitoring liver enzymes is important.

Yes.

Regular monitoring.

Annual eye exams are also often recommended due to a rare potential cataract risk.

If lavastatin isn't working after three months, it's usually stopped.

And a really critical instruction.

Report any unexplained muscle pain, tenderness, or weakness immediately.

Could be a sign of rhabdomyolysis, a rare but serious breakdown of muscle tissue.

Needs immediate attention.

And what about other antilipidic meds mentioned?

Gymfibrosil, a fibric acid derivative, shouldn't usually be used with anticoagulants.

They compete for protein binding, can affect anticoagulant levels, need dose adjustments, and more INR monitoring.

Also avoid gymfibrosil with statins increased risk of myositis, myalgias, rhabdo.

Other things.

Fish oil.

Yes.

Omega -3s, fish oil, plant stanolesterols, cholestin, red yeast rice, might have some cholesterol -lowering effects.

General nursing interventions for all antilipimics.

Monitor vitals, liver enzymes, cholesterol triglyceride levels regularly.

Emphasize adherence to diet, low -fat cholesterol, limit carbs, alcohol, and exercise.

Tell patients it takes several weeks to see lipid levels drop.

Annual eye exams.

Report vision changes, especially with statins.

Diabetics on gymfibrosil should monitor glucose closely.

Increase fluids.

Note nicotinic acid, niacin side effects.

GI upset, flushing, high liver enzyme glucoceric acid.

Taking aspirin NSAI 30 minutes before niacin might reduce flushing.

Take niacin with meals for GI comfort.

Wow.

That is truly a comprehensive run -through of a massive category of medications.

Incredible detail.

Now, let's circle back to that critical thinking question from the beginning.

Right.

The warfarin patient with an INR of 2 .8.

What should the nurse do?

Well, as our source clarifies in the critical thinking answers section, the normal INR for someone not on warfarin is about 0 .8 to 1 .2.

The usual therapeutic goal for most patients on warfarin is an INR between 2 .0 and 3 .0.

Sometimes higher, 3 .0 to 4 .5 for specific things like certain heart valves, but 2 .0 to 3 .0 is standard.

So an INR of 2 .8.

Falls squarely within that standard therapeutic range.

So in this scenario, the nurse should go ahead and administer the prescribed dose of warfarin.

Makes sense.

If it was below 2, maybe need more warfarin.

If significantly above 3, maybe hold or decrease the dose due to bleeding risk.

Exactly.

Depends on context and orders.

But 2 .8 is generally right where you want it for standard therapy.

That's a great practical application of understanding INR and warfarin.

Our source also includes practice questions at the end, right, with rationales.

Yes.

Several questions covering key concepts.

Things like patient education for warfarin, recognizing digoxin toxicity signs, understanding therapeutic APTT for heparin, beta blocker side effects, managing nitrate side effects, thrombolytic administration priorities, responding to chest pain with nitroglycerin, drug interactions with antialipimics,

nicotinic acid side effects, thiazide diuretic considerations.

A really good mix.

We won't go through each one now, but reviewing those questions and especially the rationales sounds like an excellent way to solidify understanding.

Absolutely.

They really bridge the gap from theory to clinical practice.

Test that critical thinking needed when caring for patients on these meds.

The rationales explain why an answer is right or wrong.

Invaluable for learning.

Well, that brings us to the end of our deep dive into this comprehensive chapter on cardiovascular medications from the Saunders Review source.

We've covered a frankly vast amount of information.

We really have.

From anticoagulants, antiplatelets, thrombolytics, to antihypertensives like diuretics, blockers, ACEs, ARBs,

then antianginals, cardiac glycosides, vasodilators, antialipimics.

And covering mechanisms, indications, contraindications, side effects, and those crucial nursing considerations, assessment, procedures, safety, priority actions, even that INR example.

We definitely explored those key concepts of clotting and perfusion and how these drugs directly impact them.

Talked about assessment, admin techniques, monitoring patient education.

Highlighted safety protocols and priority actions throughout.

It's just so clear how vital the nurse's role is in safely and effectively managing patients on these medications.

You really need a thorough understanding of the drugs and the patient.

Couldn't agree more.

It's essential for good outcomes and preventing problems.

And as you said, reviewing those practice questions can really help cement this knowledge.

Definitely a worthwhile step for anyone wanting to reinforce this material.

And with that, I think we can confirm we have covered all the key sections of this chapter.

It's been an incredibly detailed exploration.

Thank you for guiding us through it.

My pleasure.

Thank you.